See how company executives and directors have been buying or selling shares over the past 30 days. Insider trading activity can help investors better understand company leadership's actions.
Transactions0
Insider Involved0
Total Buys$0.00
Total Sells$0.00
Browse insider buying and selling activity reported to the SEC over the past year, including who traded, when they traded, and the value of each transaction.
No Insider Transactions found for Regulus Therapeutics Inc.
View older insider trading records reported to the SEC to research long-term buying and selling trends.
DATE INSIDER |
INSIDER | TYPE | SHARES | PRICE | SHARES PRICE VALUE |
|---|---|---|---|---|---|
Jun 03, 2025 Klassen Preston |
Klassen Preston
President & Head of R & D
|
Buy |
12,000 | $7.99 | 12,000 $7.99 $95,852 |
Jan 30, 2025 BALTIMORE DAVID |
BALTIMORE DAVID
|
Buy |
19,610 | $1.06 | 19,610 $1.06 $20,787 |
Jan 30, 2025 Hagan Joseph P |
Hagan Joseph P
CEO
|
Buy |
50,000 | $1.09 | 50,000 $1.09 $54,260 |
Jan 14, 2025 Hagan Joseph P |
Hagan Joseph P
CEO
|
Sell |
11,764 | $1.26 | 11,764 $1.26 $14,860 |
Jan 14, 2025 Aker Christopher Ray |
Aker Christopher Ray
Sr. VP & General Counsel
|
Sell |
5,088 | $1.26 | 5,088 $1.26 $6,427 |
Jan 14, 2025 CALSADA CRISPINA |
CALSADA CRISPINA
CFO
|
Sell |
5,088 | $1.26 | 5,088 $1.26 $6,427 |
Jan 13, 2025 Hagan Joseph P |
Hagan Joseph P
CEO
|
Sell |
115,290 | $1.26 | 115,290 $1.26 $145,634 |
Jan 13, 2025 Klassen Preston |
Klassen Preston
President & Head of R & D
|
Sell |
31,445 | $1.26 | 31,445 $1.26 $39,721 |
Jan 13, 2025 Aker Christopher Ray |
Aker Christopher Ray
Sr. VP & General Counsel
|
Sell |
38,547 | $1.26 | 38,547 $1.26 $48,693 |
Jan 13, 2025 CALSADA CRISPINA |
CALSADA CRISPINA
CFO
|
Sell |
38,716 | $1.26 | 38,716 $1.26 $48,906 |
Jul 25, 2024 Collier Kathryn J |
Collier Kathryn J
|
Buy |
4,000 | $1.82 | 4,000 $1.82 $7,280 |
Jan 18, 2024 Hagan Joseph P |
Hagan Joseph P
CEO
|
Sell |
14,580 | $1.19 | 14,580 $1.19 $17,359 |
Jan 18, 2024 CALSADA CRISPINA |
CALSADA CRISPINA
CFO
|
Sell |
5,468 | $1.19 | 5,468 $1.19 $6,510 |
Jan 18, 2024 Aker Christopher Ray |
Aker Christopher Ray
Sr. VP & General Counsel
|
Sell |
5,468 | $1.19 | 5,468 $1.19 $6,510 |
Feb 04, 2022 Drygin Denis |
Drygin Denis
Chief Scientific Officer
|
Buy |
23,314 | $0.23 | 23,314 $0.23 $5,362 |
May 17, 2021 Hagan Joseph P |
Hagan Joseph P
President and CEO
|
Sell |
4,186 | $0.89 | 4,186 $0.89 $3,726 |
May 17, 2021 Aker Christopher Ray |
Aker Christopher Ray
Sr. VP & General Counsel
|
Sell |
860 | $0.89 | 860 $0.89 $765 |
Feb 16, 2021 Aker Christopher Ray |
Aker Christopher Ray
Sr. VP & General Counsel
|
Sell |
828 | $1.72 | 828 $1.72 $1,424 |
Feb 16, 2021 Hagan Joseph P |
Hagan Joseph P
President and CEO
|
Sell |
4,144 | $1.72 | 4,144 $1.72 $7,128 |
Dec 04, 2020 Growth Equity Opportunities V, LLC |
Growth Equity Opportunities V, LLC
|
Buy |
5,239,254 | $0.13 | 5,239,254 $0.13 $1,307,781 |
TOP
